15/11/2025
LA VICTOIRE APPROCHE 💫
Chinese researchers have reportedly developed a stem cell therapy that reverses both Type 1 and Type 2 diabetes, marking a potential end to lifelong insulin dependence. By reprogramming fat cells into insulin-producing islet cells, patients are achieving normal blood sugar levels—without transplants, immune suppression, or medication.
While this breakthrough offers new hope for over 500 million diabetics, it also threatens the multibillion-dollar insulin industry that profits from long-term treatment. Experts predict fierce resistance from pharmaceutical giants, but public demand and global collaboration could turn this into a historic shift in healthcare.